51407-112-30 : NDC 2026 Code

51407-112-30 : Emtricitabine And Tenofovir Disoproxil Fumarate ( Emtricitabine And Tenofovir Disoproxil Fumarate )

Additionally :

You can get information about “51407-112-30” NDC code in 51407-112-30 in HTML format

HTML | 51407-112-30 in TXT (Plain Text) format

TXT | 51407-112-30 in PDF (Portable Document Format)

PDF | 51407-112-30 in XML format

XML formats.

NDC Code : 51407-112-30 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "51407-112-30",
    "PackageDescription": "30 TABLET in 1 BOTTLE, PLASTIC (51407-112-30) ",
    "NDC11Code": "51407-0112-30",
    "ProductNDC": "51407-112",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Emtricitabine And Tenofovir Disoproxil Fumarate",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Emtricitabine And Tenofovir Disoproxil Fumarate",
    "DosageFormName": "TABLET",
    "RouteName": "ORAL",
    "StartMarketingDate": "20210113",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA091055",
    "LabelerName": "Golden State Medical Supply, Inc.",
    "SubstanceName": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
    "StrengthNumber": "200; 300",
    "StrengthUnit": "mg/1; mg/1",
    "Pharm_Classes": "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2024-05-02",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20210409",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}